Prognostic factors of disease progression in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan
Background: An early 3-day course of remdesivir treatment was recommended for high risk patients with mild-to-moderate COVID-19. We investigated the prognostic factors of disease progression and mortality in patients with mild-to-moderate COVID-19 on early remdesivir treatment in Taiwan. Methods: Ad...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Elsevier
2025-05-01
|
| Seri Bilgileri: | Journal of Infection and Public Health |
| Konular: | |
| Online Erişim: | http://www.sciencedirect.com/science/article/pii/S1876034125000541 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|